Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands

Jochems, A.; Schouwenburg, M.G.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J.M. van den; Haanen, J.B.A.G.; ... ; Hoeven, J.J.M. van der (2017)

Article / Letter to editor

• Quality assurance
• Metastatic melanoma
• Checkpoint inhibitors
• MAP kinase inhibitors
• Population-based
• Registry
• Ipilimumab

• All authors: Jochems, A.; Schouwenburg, M.G.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J.M. van den; Haanen, J.B.A.G.; Gelderblom, H.; Uyl-de Groot, C.A.; Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; Blokx, W.A.M.; Cardous-Ubbink, M.C.; Groenewegen, G.; Groot, J.W.B. de; Hospers, G.A.P.; Kapiteijn, E.; Koornstra, R.H.; Kruit, W.H.; Louwman, M.W.; Piersma, D.; Rijn, R.S. van; Tije, A.J. ten; Vreugdenhil, G.; Wouters, M.W.J.M.; Hoeven, J.J.M. van der
• Date: 2017-02-28
• Journal: European Journal of Cancer
• Volume: 72
• Pages: 156 - 165
• DOI: doi:10.1016/j.ejca.2016.11.021